Moving forward, perhaps no recent development in the use of RT in metastatic prostate cancer has captured greater attention than the use of radium-223 in metastatic castration-resistant prostate cancer (mCRPC).
Kristopher Dennis, MD, FRCPC
Advertisement
Articles by Kristopher Dennis, MD, FRCPC
Patients with advanced progressive cancer require care plans that address their physical, emotional, and psychosocial needs, as well as their goals of care.
Advertisement
Latest Updated Articles
- Palliative RT Research in Prostate Cancer: Understanding the Past, Anticipating the Future
Published: April 15th 2014 | Updated:
- Palliative Care and Oncology: Integration Leads to Better Care
Published: November 30th 2011 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ASH 2025: Key Anticipated Updates in the Leukemia Landscape
2
ASH 2025: Which Presentations Will Move the Multiple Myeloma Needle?
3
Real-World Elranatamab Maintains Responses in Elderly, Frail R/R Multiple Myeloma
4
Fixed-Duration Venetoclax Combos Show Noninferior PFS to Ibrutinib in CLL
5
